Howard L. Kaufman - Publications, H-index & Citations

Back

Howard L. Kaufman

c harvard medical school

76H-index

538Paper Count

2.7WCitation Count

Published Papers 125

Publication Date

Opportunities and challenges in the clinical application of anticancer virotherapy

Expert Review of Anticancer Therapy

IF2.8

2025-11-06

OAAI

Kailan Sierra-Davidson; Sonia Cohen; Kevin S. Emerick; Howard L. Kaufman

Save

Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors

Cancer Gene Therapy

IF5

2025-09-16

OAAI

Myla Hudson; Robert H. Newman; Checo J. Rorie; Bryan L. Holloman; Howard L. Kaufman; Samuel D. Rabkin; Joseph Graves; Dipongkor Saha

Save

Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference

OncoImmunology

IF6.3

2025-05-22

OAAI

Fereshteh Talebi; Fabiana Gregucci; Jalal Ahmed; Nir Ben Chetrit; Brian D. Brown; Timothy A. Chan; Dhan Chand; Julie Constanzo; Sandra Demaria; Dmitry I. Gabrilovich; Encouse Golden; Andrew Godkin; Chandan Guha; Gaorav P. Gupta; Aisha Hasan; Fernanda G. Herrera; Howard Kaufman; Donna Li; Alan A. Melcher; Sierra McDonald; Taha Merghoub; Arta M. Monjazeb; Sébastien Paris; Sean Pitroda; Anguraj Sadanandam; Dörthe Schaue; Laura Santambrogio; Phillippe Szapary; Julien Sage; James W. Welsh; Anna Wilkins; Kristina H. Young; Eric Wennerberg; Laurence Zitvogel; Lorenzo Galluzzi; Eric Deutsch; Silvia C. Formenti

Save

Using oncolytic viruses to induce hyperacute rejection against cancer

NATURE REVIEWS CLINICAL ONCOLOGY

IF82.2

2025-02-26

PREAI

Kaufman, Howard L.; Silk, Ann W.

Save

Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide-Tethered IL-12 in Dogs with Advanced Malignant Melanoma

MOLECULAR CANCER THERAPEUTICS

IF5.5

2024-12-23

PREAI

Barbosa, Matheus Moreno Passos; Kamerer, Rebecca L.; Schmit, Joanna; Lopez, Angel J.; Uyehara, Rachel; Tighe, Robert; Battula, Sailaja; Kaufman, Howard L.; Fan, Timothy M.

Save

ASO Visual Abstract: Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparepvec-A Single-Institution Retrospective Analysis

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-12-09

PREAI

Sierra-Davidson, Kailan; Dedeilia, Aikaterini; Lawless, Aleigha; Sharova, Tanya; Kaufman, Howard L.; Boland, Genevieve M.; Cohen, Sonia

Save

Understanding the interplay between oHSV and the host immune system: Implications for therapeutic oncolytic virus development

MOLECULAR THERAPY

IF12

2024-12-01

PREAI

Ayele, Kalkidan; Wakimoto, Hiroaki; Nauwynck, Hans J.; Kaufman, Howard L.; Rabkin, Samuel D.

Save

Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2024-10-23

OAAI

Fabian, Kellsye P.; Santiago-Sanchez, Ginette; Padget, Michelle R.; Lassoued, Wiem; Allen, Clint Tanner; Battula, Sailaja; Kaufman, Howard; Hodge, James W.

Save

Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial

NATURE COMMUNICATIONS

IF15.7

2024-08-27

OAAI

Mooradian, Meghan J.; Fintelmann, Florian J.; LaSalle, Thomas J.; Simon, Judit; Graur, Alexander; Muzikansky, Alona; Mino-Kenudson, Mari; Shalhout, Sophia; Kaufman, Howard L.; Jenkins, Russell W.; Lawrence, Donald; Lawless, Aleigha; Sharova, Tatyana; Uppot, Raul N.; Fang, Jacy; Blaum, Emily M.; Gonye, Anna L. K.; Gushterova, Irena; Boland, Genevieve M.; Azzoli, Christopher; Hacohen, Nir; Sade-Feldman, Moshe; Sullivan, Ryan J.

Save

Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2024-05-31

OAAI

Wang, Hongbin; Borlongan, Mia; Kaufman, Howard L.; Le, Uyen; Nauwynck, Hans J.; Rabkin, Samuel D.; Saha, Dipongkor

Save

The prognostic value of the Merkel cell polyomavirus serum antibody test: A dual institutional observational study

CANCER

IF5.1

2024-05-02

PREAI

Miller, David M.; Shalhout, Sophia Z.; Wright, Kayla M.; Miller, Matt A.; Kaufman, Howard L.; Emerick, Kevin S.; Reeder, Harrison T.; Silk, Ann W.; Thakuria, Manisha

Save

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2024-04-09

OAAI

Bommareddy, Praveen K.; Wakimoto, Hiroaki; Martuza, Robert L.; Kaufman, Howard L.; Rabkin, Samuel D.; Saha, Dipongkor

Save

Anchored IL-12 synergizes with an epigenetic modulator to promote immune remodeling and overcome anti-PD1-refractory murine tumors

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Khelifa, Asma S.; Lothstein, Katherine L.; Miyamoto, Masaya; Tighe, Rob; Battula, Sailaja; Kaufman, Howard L.; Schlom, Jeffrey; Gameiro, Sofia R.

Save

Phase II study of cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Mooradian, Meghan J.; Fintelmann, Florian J.; LaSalle, Thomas J.; Simon, Judit; Graur, Alexander; Muzikansky, Alona; Mino-Kenudson, Mari; Shalhout, Sophia; Kaufman, Howard L.; Jenkins, Russell W.; Lawrence, Donald; Lawless, Aleigha; Sharova, Tatyana; Uppot, Raul N.; Fang, Jacy; Blaum, Emily M.; Gonye, Anna L.; Gushterova, Irena; Boland, Genevieve M.; Hacohen, Nir; Sade-Feldman, Moshe; Sullivan, Ryan J.

Save

Intratumoral aluminum hydroxide- anchored IL-12 drives potent antitumor activity by remodeling the tumor microenvironment

JCI INSIGHT

IF6.1

2023-12-08

OAAI

Battula, Sailaja; Papastoitsis, Gregory; Kaufman, Howard L.; Wittrup, K. Dane; Schmidt, Michael M.

Save

Preclinical pharmacokinetic (PK) and tumor growth inhibition (TGI) modeling for mANK-101, an anchored murine interleukin-12 (IL-12) complex for intratumoral administration for solid cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-12-01

PREAI

Mistry, Hitesh; Hodson, David; Orrell, David; Battula, Sailaja; Emens, Leisha A.; Kaufman, Howard L.; Schmidt, Michael M.

Save

Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2023-07-19

OAAI

Goldufsky, Josef W.; Daniels, Preston; Williams, Michael D.; Gupta, Kajal; Lyday, Bruce; Chen, Tony; Singh, Geeta; Kaufman, Howard L.; Zloza, Andrew; Marzo, Amanda L.

Save

Increased risk of cutaneous immune- related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2023-06-01

OAAI

Leung, Bonnie W.; Wan, Guihong; Nguyen, Nga; Rashdan, Hannah; Zhang, Shijia; Chen, Wenxin; Cohen, Sonia; Boland, Genevieve M.; Sullivan, Ryan J.; Fadden, Riley M.; Kaufman, Howard L.; Kwatra, Shawn G.; LeBoeuf, Nicole R.; Semenov, Yevgeniy R.

Save

Preliminary results of an exploratory phase I clinical trial of anchored canine interleukin-12 (cANK-101) in dogs with advanced oral malignant melanoma

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Barbosa, Matheus Moreno Passos; Lopez, Angel J.; Uyehara, Rachel; Kamerer, Rebecca L.; Schmidt, Michael; Battula, Sailaja; Kaufman, Howard L.; Fan, Timothy M.

Save

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma

FRONTIERS IN ONCOLOGY

IF3.3

2023-02-09

OAAI

Silk, Ann W.; Curti, Brendan; Bryan, Jennifer; Saunders, Tracie; Shih, Weichung; Kane, Michael P.; Hannon, Phoebe; Fountain, Christopher; Felcher, Jessica; Zloza, Andrew; Kaufman, Howard L.; Mehnert, Janice M.; McDermott, David F.

Save

Research Directions